News

PEPFAR keeps millions of people with HIV alive and may be spared from Trump spending cuts
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...
AllAfrica on MSN2d
Momentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To Action
New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
Fierce Biotech2d
Merck wades deeper into HIV PrEP waters dominated by Gilead with 2 new late-stage trials
Even with the HIV prevention waters now dominated by Gilead Science’s Yeztugo (lenacapavir), Merck & Co. is not afraid to swim deeper in. | Even with the HIV prevention waters now dominated by Gilead ...
Tribune Online on MSN4d
Despite decades of awareness, HIV patients still suffer stigmatization
In the brightly lit corridors of a Nigerian hospital, an unspoken fear lingers, not just among patients, but among the very hands trained to heal them. In spite of decades of awareness campaigns, ...
Opinion
How the end of USAID is playing out in this ‘rape capital of the world’
Ending USAID could lead to the deaths of 14 million people over the next five years, an analysis from a medical journal predicts.